Mar. 10 at 7:38 PM
Stocks rose Tuesday as oil prices declined, while several companies saw sharp moves on news and analyst actions.
Vertex Pharmaceuticals jumped about 9% after its kidney-disease drug povetacicept met the primary endpoint in a late-stage trial. BioNTech fell roughly 19% after issuing weak 2026 revenue guidance and announcing that its co-founders will depart by year-end to start a new biotech venture.
Centene dropped around 14% after reiterating a 2026 adjusted EPS outlook above
$3, roughly in line with expectations. Rivian Automotive gained about 6.5% after TD Cowen upgraded the stock to Buy with a
$20 price target.
Shares of NIO surged about 13% after reporting a surprise Q4 profit and strong Q1 guidance. Paramount Global fell about 7.7% after BofA cut its price target and maintained an Underperform rating.
$VRTX $BNTX $CNC $NIO $HPE